Aptevo Therapeutics Inc.
APVO
$4.83
-$0.02-0.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.81M | -7.55M | -6.20M | -6.41M | -6.31M |
| Total Depreciation and Amortization | 81.00K | 49.00K | 49.00K | 61.00K | 71.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.09M | 77.00K | -163.00K | 180.00K | 1.03M |
| Change in Net Operating Assets | -602.00K | 735.00K | -775.00K | -408.00K | -546.00K |
| Cash from Operations | -5.24M | -6.69M | -7.09M | -6.58M | -5.76M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.79M | 18.34M | 14.36M | -- | 6.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 472.00K |
| Cash from Financing | 5.79M | 18.34M | 14.36M | -- | 6.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 558.00K | 11.65M | 7.27M | -6.58M | 961.00K |